As per AWACS data, Indian pharmaceutical market expanded 12.1% in August

6 Sep 2022 , 08:09 AM

According to market research company AWACS, the Indian pharmaceutical market (IPM) expanded well across all therapy categories in August, growing 12.1% in value and 4.8% in volume.

In August, IPM had sales of Rs16,239 crore.

The pharmaceutical industry has increased prices for pharmaceuticals subject to price regulation and infectious disorders associated with the monsoon thanks to the wholesale pricing index (WPI) inflation-linked price hike permitted by the government.

The categories with the fastest growth rates were cardiac (13% growth), anti-infectives (13% growth), and gastrointestinal (12% growth). Vitamin sales and anti-diabetes sales both increased by 9%.

The top three selling brands in India continue to be Abbott’s Mixtard, GSK’s Augmentin, and USV’s Glycomet.

For feedback and suggestions, write to us at [e-mail]